trial
as of 2026-07-01Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms
NCTId NCT02529163
at a glance
— · Unknown
Enrollment 24 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2017-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
24 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Single
Start
2015-08
Primary completion
2017-12
Eligibility
ALL · 50 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Petal Abdool, MDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
24
Phase
NA
Primary Completion Date
2017-12
Status
UNKNOWN
relationships
The graph out of here
drug
lead_sponsor
indication
investigator
person